Connecticut Adds Qualifying Conditions for Medical Marijuana

HARTFORD, CT — Patients with severe rheumatoid arthritis, spasticity disorders, and neuropathic facial pain are among those who are now eligible for marijuana therapy following a decision this week by regulators to expand the program’s list of qualifying conditions.

Under the just-announced rules, doctors may for the first time recommend medical cannabis to patients with the following diagnoses: spasticity, severe rheumatoid arthritis, post herpetic neuralgia, hydrocephalus, intractable headache, neuropathic facial pain, muscular dystrophy, and osteogenesis imperfecta (aka broken bone disease).

With the additions, the qualifying conditions for medical marijuana in Connecticut are now:

  • Amyotrophic lateral sclerosis
  • Cachexia
  • Cancer
  • Cerebral Palsy
  • Complex regional pain syndrome
  • Crohn’s disease
  • Cystic Fibrosis
  • Epilepsy
  • Glaucoma
  • Hydrocephalus
  • HIV or AIDS
  • Intractable headache syndromes
  • Intractable spasticity
  • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity
  • Multiple Sclerosis
  • Muscular dystrophy
  • Neuropathic facial pain
  • Osteogenesis imperfecta
  • Parkinson’s Disease
  • Post herpetic neuralgia
  • Post-surgical back pain with a condition called chronic radiculopathy
  • Post laminectomy syndrome
  • Posttraumatic Stress Disorder (PTSD)
  • Severe psoriasis and psoriatic arthritis
  • Severe rheumatoid arthritis
  • Sickle cell disease
  • Spasticity
  • Terminal Illness Requiring End-Of-Life Care
  • Ulcerative colitis
  • Uncontrolled Intractable Seizure Disorder

Over 27,000 Connecticut are currently enrolled in the state’s medical cannabis program.

Tags: , , , , , , , , , ,

Source link

Related Posts